Active, not recruitingNCT03173300
Natural History Study Protocol in PMM2-CDG (CDG-Ia)
Studying PMM2-CDG
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Glycomine, Inc.
- Principal Investigator
- Chief Medical OfficerGlycomine, Inc.
- Enrollment
- 120 enrolled
- Eligibility
- All sexes
- Timeline
- 2018 – 2026
Study locations (11)
- Mayo Clinic College of Medicine, Rochester, Minnesota, United States
- Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, United States
- Seattle Children's Hospital, Seattle, Washington, United States
- University Hospital Leuven, Leuven, Belgium, Belgium
- General University Hospital in Prague, Prague, Czechia
- Necker Enfants-Malades Hospital, Paris, France
- University Hospital of Catania, Catania, Italy
- Radboud University Nejmegen Medical Center, Nijmegen, Netherlands
- Mother and Child Institute (Instytut Matki i Dziecka), Warsaw, Poland
- Centro Hospitalar do Porto, Porto, Portugal
- Hospital Sant Joan de Déu, Barcelona, Spain
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03173300 on ClinicalTrials.govOther trials for PMM2-CDG
Additional recruiting or active studies for the same condition.